|
Real-time Estimate
Cboe Europe
19:18:32 16/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,859.25 GBX | -0.50% |
|
+6.23% | +1.89% |
| 03:13pm | UK stocks set for weekly gains as investors seek shelter in defensive sectors | RE |
| 10-15 | Pennsylvania secures $4 billion in investments, governor says | RE |
Company Valuation: GSK plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,458 | 58,381 | 59,112 | 54,944 | 73,201 | 74,871 | - | - |
| Change | - | -27.44% | 1.25% | -7.05% | 33.23% | 2.28% | - | - |
| Enterprise Value (EV) 1 | 100,296 | 75,578 | 74,152 | 68,039 | 87,654 | 96,028 | 93,141 | 90,314 |
| Change | - | -24.65% | -1.89% | -8.24% | 28.83% | 9.55% | -3.01% | -3.04% |
| P/E | 18.6x | 3.93x | 11.9x | 21.3x | 12.9x | 14.2x | 11.8x | 11x |
| PBR | 5.34x | 5.47x | 4.4x | 4.02x | 4.51x | 4.68x | 4.11x | 3.64x |
| PEG | - | 0x | -0.2x | -0.4x | 0x | -2.07x | 0.6x | 1.6x |
| Capitalization / Revenue | 2.36x | 1.99x | 1.95x | 1.75x | 2.24x | 2.21x | 2.11x | 2.04x |
| EV / Revenue | 2.94x | 2.58x | 2.45x | 2.17x | 2.68x | 2.83x | 2.62x | 2.46x |
| EV / EBITDA | 8.85x | 7.23x | 6.37x | 6.36x | 7.77x | 8.22x | 7.53x | 7.1x |
| EV / EBIT | 11.4x | 9.27x | 8.44x | 7.44x | 8.96x | 9.28x | 8.4x | 7.8x |
| EV / FCF | 22.6x | 12.1x | 13.6x | 13x | 13.7x | 17.1x | 16.3x | 13.5x |
| FCF Yield | 4.42% | 8.28% | 7.36% | 7.67% | 7.32% | 5.84% | 6.15% | 7.39% |
| Dividend per Share 2 | 1 | 0.6125 | 0.58 | 0.61 | 0.66 | 0.6945 | 0.7477 | 0.7825 |
| Rate of return | 4.98% | 4.26% | 4% | 4.53% | 3.62% | 3.72% | 4% | 4.19% |
| EPS 2 | 1.082 | 3.662 | 1.216 | 0.632 | 1.411 | 1.314 | 1.586 | 1.695 |
| Distribution rate | 92.4% | 16.7% | 47.7% | 96.5% | 46.8% | 52.9% | 47.1% | 46.2% |
| Net sales 1 | 34,114 | 29,324 | 30,328 | 31,376 | 32,667 | 33,912 | 35,521 | 36,692 |
| EBITDA 1 | 11,330 | 10,449 | 11,635 | 10,693 | 11,278 | 11,678 | 12,372 | 12,727 |
| EBIT 1 | 8,806 | 8,151 | 8,786 | 9,148 | 9,783 | 10,345 | 11,083 | 11,574 |
| Net income 1 | 4,385 | 14,956 | 4,928 | 2,575 | 5,716 | 5,322 | 6,308 | 6,756 |
| Net Debt 1 | 19,838 | 17,197 | 15,040 | 13,095 | 14,453 | 21,157 | 18,270 | 15,443 |
| Reference price 2 | 20.08 | 14.38 | 14.50 | 13.46 | 18.24 | 18.68 | 18.68 | 18.68 |
| Nbr of stocks (in thousands) | 4,006,383 | 4,060,999 | 4,076,145 | 4,080,519 | 4,012,126 | 4,007,011 | - | - |
| Announcement Date | 09/02/22 | 01/02/23 | 31/01/24 | 05/02/25 | 04/02/26 | - | - | - |
1GBP in Million2GBP
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14.22x | 2.83x | 8.22x | 3.72% | 99.22B | |
| 35.8x | 12.9x | 27.02x | 0.55% | 1,116B | |
| 37.07x | 6.25x | 17.38x | 2.11% | 610B | |
| 36.17x | 8.31x | 17.13x | 2.45% | 501B | |
| 112.15x | 5.92x | 25.35x | 2.35% | 358B | |
| 20.49x | 5x | 12.4x | 2.64% | 366B | |
| 21.24x | 5.55x | 13.66x | 2.88% | 288B | |
| 22x | 4.43x | 12.71x | 1.99% | 261B | |
| 27.56x | 7.08x | 12.68x | 2.32% | 235B | |
| -45.98x | 7.04x | 27.26x | 2.1% | 195B | |
| Average | 28.07x | 6.53x | 17.38x | 2.31% | 402.9B | |
| Weighted average by Cap. | 34.53x | 8.04x | 19.69x | 1.89% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- GSK Stock
- Valuation GSK plc
Select your edition
All financial news and data tailored to specific country editions
